Navigation Links
FDA New Guidelines for Biosimilars and Biobetters: An Outlook for 2013
Date:1/14/2013

Toronto, Canada (PRWEB) January 14, 2013

The FDA plans to use a 'totality of the evidence' approach for approving Biosimilars. Evaluation of all available data submitted in support of the Biosimilarity of the proposed product, and the type or amount of analyses and testing required ensuring safety, purity, or potency will be determined on a product-specific basis.

The development of Biosimilars have garnered great interest for their cost-effective benefits in patient care as well as developmental opportunities for industry sponsors who see a new revenue stream. However, the pathway to commercialization is complicated by regulatory challenges. There is still a need to understand the expected requirements for biosimilar registration, as well as focused data requirements to establish a viable, safe and effective product.

The goal of this presentation is to provide an understanding of the current regulations and continued challenges, future directions by the regulatory authorities and provide insight to the regulatory pathway for biosimilar and biobetter registration.

A live Q&A with the audience will follow the main presentation. For more information, or to register for this event please go to http://xtks.in/xto555.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com/ContactUs.ashx

Contact:
Ka
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. UBM Conferences Unveils Details for Upcoming Generics and Biosimilars Conference
2. Biosimilars: Global Markets
3. Despite Recession, Global Biosimilars Market Grew Over 40% 2010-2011, Set to Reach $3.6 Billion by 2016
4. Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway
5. Europe Anesthesia and Respiratory Devices Market Outlook to 2018 - Respiratory Devices, Respiratory Measurement Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and Others
6. Cancer Antibodies: Drug Target Atlas and Competitive Outlook
7. Orthobiologics Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018: China Market Research Reports
8. Biomarkers: Technological and Commercial Outlook 2012-2022
9. Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Palls Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
10. 2012 US Coagulation Market Outlook: Growth Opportunities and Strategies
11. 2012 Global Factor Assays Market Outlook: Test Volume Forecasts by Country and Market Segment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... (PRWEB) June 18, 2013 As ... MeMD, Inc proudly announces the release of their ... and Fitness ". , MeMD's goal was to ... landscape of Health 2.0, Health 3.0 and mHealth.The ... likely transform medical care and the fitness industry ...
(Date:6/18/2013)... 18, 2013 New user friendly innovations ... prevent the dangers of misuse and ineffective sterilization. ... analog pressure gauges, hot surfaces and complex door latches. ... new, modern autoclave, Revolutionary Science explains some important points ... Older autoclave designs will recycle dirty water. This ...
(Date:6/18/2013)... On June 11, 2013 the Centers for Medicare ... memorandum concluding that FDG Position Emission Tomography (PET) is ... strategy, and the agency ended the requirement for ... was developed jointly by the ACR and WMIS as ... Evidence Development (CED) program to determine if FDG-PET scans ...
(Date:6/17/2013)... SAN FRANCISCO , June 17, 2013  KaloBios ... the appointment of Donald R. Joseph as ... 20 years of biopharmaceutical industry experience and has worked ... major global health non-profit organizations. (Logo: ... and successful track record as a general counsel and ...
Breaking Biology Technology:MeMD, Inc Releases Infographic Featuring the Top Eight Technologies that are Revolutionizing Health and Fitness Today 2How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 2KaloBios Appoints Donald R. Joseph as Chief Legal Officer 3KaloBios Appoints Donald R. Joseph as Chief Legal Officer 4
... - Premacure to Initiate Phase II Trial for ... and UPPSALA, Sweden, Sept. 23 ,Insmed Inc. (Nasdaq ... biopharmaceuticals, and Premacure AB, a biopharmaceutical company,dedicated to ... neonates due to premature birth, today noted the ...
... Codexis, Inc., today,announced the appointment of Lynn ... be responsible for managing the company,s,intellectual property strategy, ... Sheehy, Vice President, General Counsel and Secretary., ... as Senior,Director, Intellectual Assets US, she managed the ...
... Sept. 23 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc.,(TSX: SDI) ... terms with Toray,Industries Inc. of Japan to obtain ... for Toraymyxin(TM), a therapeutic for the treatment of,sepsis ... terms of the,agreement, the Company will seek FDA ...
Cached Biology Technology:Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 2Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 3Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 4Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants 5Codexis Names Vice President, Intellectual Property 2Spectral to bring anti-sepsis therapy to the U.S. market 2Spectral to bring anti-sepsis therapy to the U.S. market 3
(Date:6/17/2013)... -- A Kansas State University research associate has received ... and ways to prevent the spread of malaria. , ... National Institutes of Health,s National Research Service Award Individual ... is the seventh Kansas State University researcher to receive ... to currently hold such an award. , Bryant, a ...
(Date:6/17/2013)... available in French . ... older mice with Alzheimer,s disease can be reversed with treatment. ... Hospital - The Neuro, at McGill University and at Universit ... receptor in the brain of mice with advanced Alzheimer,s disease ... the Journal of Neuroinflammation in May, also suggest ...
(Date:6/15/2013)... in Europe to treat osteoporosis has now been shown ... in cancers that have become resistant to current targeted ... The findings, presented June 15, 2013, at the annual ... drug bazedoxifene packs a powerful one-two punch that not ... but also flags the estrogen receptor for destruction. , ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2
... ant species and a carnivorous plant, the ants contribute to ... provide significant amounts of nutrients derived from their wastes. This ... May 9 in the open access journal PLoS ... bicalcarata grows in the nutrient-poor peatswamp forests of Borneo ...
... in farming areas that supports ladybugs could help increase their ... reduce their costs, says a Michigan State University study. ... an estimated $4.6 billion a year on insecticides. Non-crop plants ... to survive and thrive in areas where they are needed. ...
... hair cells, which produce electrical signals in response to vibrations ... age- or trauma-related hearing loss. One way to do this ... cells to grow. Researchers at Emory University School of ... the cochleae of young mice can induce the formation of ...
Cached Biology News:Increasing predator-friendly land can help farmers reduce costs 2Gene therapy for hearing loss: Potential and limitations 2
Rabbit polyclonal to JNK1 (phospho T183 + Y185) ( Abpromise for all tested applications). entrezGeneID: 5599 SwissProtID: P45983...
Cytofix Buffer 100 mls...
Perm/Wash Buffer 250 Tests...
The BD PhosFlow Fix Buffer I can be used for the simultaneous fixation and permeabilization of cells prior to intracellular staining. Applications: Intracellular Staining (Flow) Storage Temperature:...
Biology Products: